Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

fractionated stereotactic radiotherapy

  • You have access
    Treatment Outcomes After Higher-dose Fractionated Stereotactic Radiotherapy (FSRT) Alone for 1-4 Brain Metastases
    LEONIE JOHANNWERNER, ELISA M. WERNER, STEFAN JANSSEN, NATHAN Y. YU and DIRK RADES
    Anticancer Research June 2023, 43 (6) 2757-2762; DOI: https://doi.org/10.21873/anticanres.16443
  • Open Access
    Stereotactic Radiotherapy or Whole-Brain Irradiation Plus Simultaneous Integrated Boost After Resection of Brain Metastases
    DIRK RADES, LEONIE JOHANNWERNER, NATHAN Y. YU and JAN GLIEMROTH
    Anticancer Research June 2023, 43 (6) 2763-2770; DOI: https://doi.org/10.21873/anticanres.16444
  • Open Access
    A Survival Score for Very Elderly Patients With Brain Metastases Assigned to Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy
    DIRK RADES, CANSU DELIKANLI, OLIVER BLANCK, STEVEN E. SCHILD and STEFAN JANSSEN
    Anticancer Research November 2022, 42 (11) 5629-5634; DOI: https://doi.org/10.21873/anticanres.16071
  • You have access
    Predicting the Risk of Subsequent Distant Brain Metastases After Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy in Elderly Patients
    DIRK RADES, TRANG NGUYEN, LIESA DZIGGEL, OLIVER BLANCK and STEVEN E. SCHILD
    Anticancer Research July 2020, 40 (7) 4081-4086; DOI: https://doi.org/10.21873/anticanres.14406
  • You have access
    Fractionated Stereotactic Sequential Boost in a Selected Cohort of Glioblastoma Patients: A Mono-institutional Analysis
    ALESSANDRO MARCHIONNI, ISABELLA PALUMBO, GIAMPAOLO MONTESI, VITTORIO BINI, CLAUDIO ZUCCHETTI, NUNZIA CENCI, PIETRO CHIARINI, STEFANO SACCIA, CYNTHIA ARISTEI and MARCO LUPATTELLI
    Anticancer Research June 2020, 40 (6) 3387-3393; DOI: https://doi.org/10.21873/anticanres.14322
  • You have access
    Predicting the Risk of Developing New Cerebral Lesions After Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Brain Metastases from Renal Cell Carcinoma
    DIRK RADES, LIESA DZIGGEL, OLIVER BLANCK, NIKLAS GEBAUER, TOBIAS BARTSCHT and STEVEN E. SCHILD
    Anticancer Research May 2018, 38 (5) 2973-2976;
  • You have access
    A Score to Identify Patients with Brain Metastases from Colorectal Cancer Who May Benefit from Whole-brain Radiotherapy in Addition to Stereotactic Radiosurgery/Radiotherapy
    DIRK RADES, LIESA DZIGGEL, OLIVER BLANCK, NIKLAS GEBAUER, TOBIAS BARTSCHT and STEVEN E. SCHILD
    Anticancer Research May 2018, 38 (5) 3111-3114;
  • You have access
    Early Manifestation of Communicating Hydrocephalus After Fractionated Stereotactic Radiotherapy for Aggressive Giant Atypical Prolactinoma
    KAZUHIRO OHTAKARA, NAOYUKI OHE, TORU IWAMA and HIROAKI HOSHI
    Anticancer Research May 2014, 34 (5) 2509-2515;
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire